MedicarePartD.guide

A non-government resource built from CMS public data

Fetzima on Blue MedicareRx Essentials (S5726-020)

levomilnacipran hydrochloride

Covered.

Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.

$168.93
Patient pays / month, after deductible
$563.09
Patient pays / month, before the $615.00 deductible
$506.78
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

FETZIMA 20 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $563.09 for a month. Other covered strengths are listed below.

All 5 covered strengths and forms
FormTierPatient pays / monthLimits
FETZIMA 120 mg Capsule, Extended Release4$169.6430 per 30 days
FETZIMA 20 mg Capsule, Extended Release4$168.9330 per 30 days
FETZIMA 40 mg Capsule, Extended Release4$172.9130 per 30 days
FETZIMA 80 mg Capsule, Extended Release4$170.8030 per 30 days
FETZIMA Kit4$173.6928 per 28 days

Verify with the plan before prescribing or filling. Member services: (866)421-5077. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5726-020